The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era
- PMID: 28444206
- PMCID: PMC5850410
- DOI: 10.1093/cid/cix341
The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era
Abstract
We compared estimated costs of retesting human immunodeficiency virus (HIV)-positive persons before antiretroviral therapy (ART) initiation to the costs of ART provision to misdiagnosed HIV-negative persons. Savings from averted unnecessary ART costs were greater than retesting costs within 1 year using assumptions representative of HIV testing performance in programmatic settings. Countries should implement re-testing before ART initiation.
Keywords: HIV testing; antiretroviral treatment; cost-benefit analysis; misdiagnosis.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
Similar articles
-
Cost implications of HIV retesting for verification in Africa.PLoS One. 2019 Jul 1;14(7):e0218936. doi: 10.1371/journal.pone.0218936. eCollection 2019. PLoS One. 2019. PMID: 31260467 Free PMC article.
-
Identification of misdiagnosed HIV clients in an Early Access to ART for All implementation study in Swaziland.J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21756. doi: 10.7448/IAS.20.7.21756. J Int AIDS Soc. 2017. PMID: 28872273 Free PMC article. Clinical Trial.
-
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.Lancet Glob Health. 2021 May;9(5):e668-e680. doi: 10.1016/S2214-109X(21)00034-6. Epub 2021 Mar 12. Lancet Glob Health. 2021. PMID: 33721566 Free PMC article.
-
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.PLoS Med. 2021 Sep 14;18(9):e1003712. doi: 10.1371/journal.pmed.1003712. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34520463 Free PMC article.
-
The lifetime cost of current human immunodeficiency virus care in the United States.Med Care. 2006 Nov;44(11):990-7. doi: 10.1097/01.mlr.0000228021.89490.2a. Med Care. 2006. PMID: 17063130 Review.
Cited by
-
Cost and Cost-Effectiveness of Distributing HIV Self-Tests within Assisted Partner Services in Western Kenya.Healthcare (Basel). 2024 Sep 25;12(19):1918. doi: 10.3390/healthcare12191918. Healthcare (Basel). 2024. PMID: 39408099 Free PMC article.
-
The Effects of Workplace-Based HIV Self-testing on Uptake of Testing and Linkage to HIV Care or Prevention by Men in Uganda (WISe-Men): Protocol for a Cluster Randomized Trial.JMIR Res Protoc. 2021 Nov 1;10(11):e25099. doi: 10.2196/25099. JMIR Res Protoc. 2021. PMID: 34723826 Free PMC article.
-
Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis.Open Forum Infect Dis. 2021 May 13;8(6):ofab225. doi: 10.1093/ofid/ofab225. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34189169 Free PMC article.
-
Cost implications of HIV retesting for verification in Africa.PLoS One. 2019 Jul 1;14(7):e0218936. doi: 10.1371/journal.pone.0218936. eCollection 2019. PLoS One. 2019. PMID: 31260467 Free PMC article.
-
Towards an ultra-rapid smartphone- connected test for infectious diseases.Sci Rep. 2017 Sep 20;7(1):11971. doi: 10.1038/s41598-017-11887-6. Sci Rep. 2017. PMID: 28931860 Free PMC article.
References
-
- World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach—Second edition. 2016: 429 Available at: http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf Accessed 26 June 2016. - PubMed
-
- World Health Organization. Service delivery approaches to HIV testing and counselling (HTC): A strategic policy framework. 2012: 75. Available at: http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877_eng.pdf Accessed 1 September 2016.
-
- World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013: 269 Available at: http://www.who.int/hiv/pub/guidelines/arv2013/en/. Accessed 8 May 2017. - PubMed
-
- World Health Organization. WHO reminds national programmes to retest all newly diagnosed people with HIV. 2014. Available at: http://www.who.int/hiv/pub/vct/retest-newly-diagnosed-plhiv-full/en/ Accessed 1 September 2016.
-
- Organization WH. Consolidated guidelines on HIV testing services. 2015: 193 Available at: http://apps.who.int/iris/bitstream/10665/179870/1/9789241508926_eng.pdf. Accessed 8 May 2017.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical